Loss of mucosal barriers may let microbial toxins create mutations that drive invasion
In older-donor intestinal epithelial mosaics, barrier loss may expose surviving renewing cells to microbial toxins that create invasion-causing mutations. Failure to show increased exposure, surviving new mutations or their causal role in invasion would bound this mechanism in the tested setting
Omega Point 1.5
Stage of verification
- Hypothesis published2026-10-10
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Metabolite or ion
Genotoxic microbial toxins
Microbially produced substances that can damage genetic material in exposed cells
Where this hypothesis actsOlder-donor intestinal epithelial mosaics with verified active microbial toxin production during repair
Hypotheses on this target 1
Supplementation
Accelerated excretion
Composition restoration
What is proposed
Interrupt toxin activity to test its contribution to newly acquired invasive lineages
With whatControlled genetic model
HowCompare verified toxin-competent, toxin-deficient and complemented producer conditions, validating microbial ecology and delivered exposure
Possible result
Possible reduction in descendants whose newly acquired lesions causally contribute to sustained invasion
From the recordspecific toxin interruption reduces the acquired-lesion-mediated component

Specialised cell of an organ
Epithelial cells
Cells that form epithelial tissue
Where this hypothesis actsResident lineages in older-donor intestinal epithelial mosaics undergoing repeated repair
Hypotheses on this target 3
Function restoration
Reprogramming
Transplantation
Elimination2
Proliferation

What is proposed
Elimination
Remove a limited area of resident cells to test their protective barrier contribution
With whatPhysical or surgical intervention
HowCompare controlled small-area removal with retention and viability-preserving suppression, matching initial injury and testing functional replacement
Possible result
Possible increased toxin exposure and new invasive descendants if removal disrupts functional protection
From the recordCross retention, viability-preserving suppression and controlled small-area removal
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Removing damaged cells could improve aging tissue while briefly weakening its protection against harmful microbes. The unexpected move is that this opening might create new dangerous descendants through toxin-induced genetic changes, rather than simply give existing dangerous cells more room to grow. That route is a proposal generated by the pipeline, not a measured result.
- An active microbial producer supplies a DNA-damaging toxin near an aging intestinal lining.
- Resident cells help maintain a barrier that limits the toxin's access to cells renewing the lining.
- Removal or suppression changes the lining from functionally protective to more exposed during repair, even if apparent coverage remains.
- Increased local toxin exposure damages surviving renewal cells and may leave new inheritable genetic changes.
- Some acquired changes are proposed to cause sustained invasion by descendants, including after toxin withdrawal.
Replacing a worn window can improve a house while briefly letting rain reach the wiring. Closing the opening afterward does not necessarily undo damage that happened while it was exposed.
Where the picture breaks: Living barriers have several protective functions, and exposed cells may die, recover or leave descendants. The picture cannot establish that exposure produces an inherited change or that such a change causes invasion.
- Master questionstep 01 of 04
Radically slowing human aging is the overarching goal.
Rests on: The supplied goal makes human aging the target; it does not specify a mechanism or establish that radical slowing is achievable.
Stated in the chain - Goal pillarstep 02 of 04
Age-related damage may become entrenched when defective forms of tissue renewal gain an advantage.
Rests on: The goal of slowing aging supplies a reason to investigate persistent damage, but does not itself explain why defective renewal would gain an advantage.
AssumptionThe pillar takes as given that an advantage enjoyed by defective renewal can help make age-related damage persist; no supporting mechanism or finding is supplied at this stage.
- Gap questionstep 03 of 04
Suppressing expanding groups of related epithelial cells, the cells that form tissue linings, might remove protective competitors and allow dangerous cells to invade surrounding tissue. The question is how repeated repair distinguishes that loss of protection from beneficial removal of cells that function poorly.
Rests on: The preceding pillar identifies defective renewal as a possible source of persistent damage, but does not identify protective competitors or explain how suppressing them would release invasion.
LeapThe missing connection is why a population targeted as part of defective renewal would also restrain dangerous invasion, and how its removal would remove that restraint. This stage poses that possibility without supplying the connection.
- Hypothesisstep 04 of 04
A resident cell population could protect the intestinal lining by limiting exposure to microbial toxins that damage DNA, the material carrying genetic information. Removing that protection might let surviving renewal cells acquire inheritable genetic changes that make their descendants persistently invasive.S1
Rests on: The preceding question supplies the possibility of protective residents. S1, published in Gut microbes in 2023, reports that chemically induced mucus disruption in mice brought microbes into direct contact with the colon lining; it does not establish increased toxin delivery after resident removal in aging human tissue, new inherited changes in surviving cells, or invasion caused by those changes.
Supported by literature
What is carried, and what is not. One screened source, S1 in Gut microbes in 2023, speaks to the barrier-to-contact part of the proposed sequence: disrupted mucus allowed microbial contact in mice, without establishing the resident-removal mechanism in aging human tissue. None of the three crucial links—removal increasing delivered toxin exposure, that exposure producing surviving cells with new inherited changes, and those changes causing sustained invasion—is established by the supplied sources, individually or end to end.S1
Where the reasoning is carried by something unstated · 2
- Goal pillar. The pillar takes as given that an advantage enjoyed by defective renewal can help make age-related damage persist; no supporting mechanism or finding is supplied at this stage.
- Gap question. The missing connection is why a population targeted as part of defective renewal would also restrain dangerous invasion, and how its removal would remove that restraint. This stage poses that possibility without supplying the connection. Establish the missing link before relying on this step.
How a result here could mislead · 3
- More invasive descendants after toxin exposure could reflect survival or expansion of an already dangerous population, rather than creation of a new one. A new genetic change found alongside expansion could also be incidental. What closes it: The design requires stored ancestral samples, explicit limits on detecting rare starting populations, and reconstruction of ancestry across repeated samples. After toxin withdrawal, descendants must be compared in a shared undamaged environment, and introducing the nominated change into ancestral cells or correcting it in descendants must test whether that change causes invasion.
- A difference between toxin-producing and toxin-deficient microbes could arise from other differences in microbial behavior. Conversely, a negative result could mean that removal never increased delivered exposure, even though the producer was present. What closes it: The proposed matched microbial conditions remain an experimental target, not validated reagents. Microbial growth, metabolism, attachment and proximity must be checked alongside local toxin activity, barrier permeability—the ease with which substances cross the lining—and damage in surviving cells; equal microbial counts alone do not establish equal exposure.
- Greater descendant production or a larger share of dangerous cells could be mistaken for greater invasion. Removal-related injury, nutrients released from dead cells, or reduced displacement by neighboring cells could increase growth without the proposed new genetic cause. What closes it: The design requires separate measurements of absolute descendant production, population shares with their totals, recovered barrier function and crossing of the basement membrane, the supporting layer beneath the lining. Initial injury and dead-cell material must be matched as specified, while later toxin-caused injury remains part of the overall effect; shared-environment tests and direct tests of the acquired genetic change are still needed to attribute invasion to this route.
What would make this wrong. Within a tested setting containing a verified active producer and viable exposed cells, the proposed sequence would fail if removal did not increase delivered exposure, if increased exposure did not produce new inherited changes in surviving descendants, or if the nominated acquired changes did not cause sustained invasion. Evidence that invasion came entirely from pre-existing dangerous populations or persisted independently of the acquired changes would also defeat attribution to this route in that setting. A finite negative result would remain bounded by the tested exposure, observation period and ability to detect rare descendants. The supplied specification gives no validated dose, observation period or causal genetic change, includes an omitted continuation, and supplies no gap verdict.
What it would change. If this held, removing poorly functioning cells as part of an effort to slow human aging would also require accounting for the protection those cells provide during repair. Better function after recovery could coexist with a temporary increase in the creation of dangerous descendants. Even a successful result in the proposed older-donor intestinal model would not establish that this route occurs across aging human tissues, that blocking it prevents cancer in people, or that it radically slows aging.
Sources read · 2
Short-term mucosal disruption enables colibactin-producing E. coli to cause long-term perturbation of colonic homeostasis. · Gut microbes · 2023
“FISH analysis of the colon after five days of DSS treatment showed disruption of the mucus layer, with the microbiota in direct contact with the colonic epithelium ( ).”
Does not settle: The source does not establish that removal of a resident's barrier contribution increases the delivered colibactin dose in aging human mucosa, that exposed surviving renewing cells acquire new heritable lesions, or that such lesions causally confer sustained invasiveness on descendants. It studies DSS-induced mucus disruption in mice, not resident removal-to-repair.
The merits of in vitro versus in vivo modeling in investigation of the immune system. · Environmental toxicology and pharmacology · 2006
“The hypotheses of well-designed in vitro experiments must also be tested in intact in vivo models to determine relevance and to discard artifactual findings secondary to the in vitro environment.”
Does not settle: This abstract does not establish that resident removal increases local genotoxin exposure, that exposure creates new heritable lesions in surviving renewing human mucosal cells, or that such lesions causally drive sustained invasion. It reports no relevant population, producer, toxin dose, timescale, barrier function, mutation endpoint, lineage outcome, or invasion experiment.
The gap this hypothesis explains
Two established results predict opposite outcomes, and both cannot be right.
Does suppressing expanding cell families in aging human linings promote invasion or improve repeated repair?
Original wording · exactly as the pipeline generated it
During human aging, can suppressing expanding epithelial clones accelerate dangerous invasion by removing protective competitors, and what distinguishes this ecological release from removal of genuinely dysfunctional lineages across repeated repair?
What this question is asking
The question concerns growing families of related cells in the tissues that cover body surfaces and line organs during human aging. It asks whether suppressing those families could remove cells that restrain dangerous neighbors, allowing those neighbors to spread into surrounding tissue. It also asks how that outcome differs from removing cell families that actually damage tissue function through repeated cycles of injury and repair. The comparison is suppression versus leaving the families in place, assessed together for invasion, protection from neighboring cells, and tissue function over months to years. The question assumes that some expanding families provide protection and that expansion alone does not establish harmful behavior; the supplied sources do not establish that distinction in aging human tissues.
- Epithelium and epithelial cells
- Epithelium is tissue that covers body surfaces or lines organs; epithelial cells make up that tissue. These are the cells whose expanding families the question proposes suppressing.
- Clone, cell family, and lineage
- A clone is a family of cells descended from a common ancestor cell; lineage refers to that ancestry and its descendants. These terms describe relatedness, not whether the cells are healthy, harmful, or protective.
- Clonal expansion
- An increase in the number or tissue share of cells belonging to one family. Expansion alone does not specify what happens to tissue function or invasion.
- Suppression
- Reducing a cell family's growth or abundance. The supplied question does not specify a method or establish that suppression removes the family completely.
- Aged human mosaic
- An aging human tissue containing a mixture of cell families with different characteristics. The question asks how changing that mixture affects function and invasion.
- Cell competition and protective competitor
- Cell competition describes interactions that affect which cells persist or expand alongside others. A protective competitor is a cell family whose presence restrains dangerous neighbors; that protective role is an assumption to evaluate here.
- Ecological release
- Expansion or spread that becomes possible after a restraining competitor is removed. In this question, it names the proposed causal link between suppressing one cell family and increased invasion by another.
- Invasion
- Spread of cells into surrounding tissue beyond their previous location. It differs from simply increasing the number of cells within an existing tissue region.
- Stroma and stromal signaling
- Stroma is the supporting tissue around other tissue structures. Stromal signaling means messages from that supporting tissue that influence nearby cells; the premise proposes that such messages can enhance invasion.
- Dysfunctional lineage
- A cell family that impairs tissue work, appropriate control of growth, or the performance of specialized cell roles. It is a functional description, not a designation established merely by expansion.
- Specialization, growth control, and repeated repair
- Specialization means cells performing their particular tissue jobs; growth control means regulation of when and how much cells multiply. Repeated repair means successive episodes of restoring damaged tissue, across which the question requires function to be maintained.
- Adhesion
- Attachment between cells. S4 reports reduced attachment alongside increased competition, without establishing the aging-related consequences of competitor removal.
- Epithelial-to-mesenchymal transition
- A change in which lining cells acquire characteristics associated with less tightly attached, more mobile cell states. The term covers a range of changes rather than a single all-or-nothing switch; S3 reports its induction, not the suppression outcome asked about here.
- Gene, genetic change, and protein
- A gene is a stretch of inherited cellular information, and a genetic change is an alteration in that information. Proteins are molecules that carry out many cellular tasks; the supplied studies include removal of a gene and induction of a protein, which are different interventions from suppressing an expanding cell family.
- Cell line and transplanted tumor
- A cell line is a population of cells maintained for study outside its original tissue. A transplanted tumor is tumor tissue or tumor-forming cells placed into a recipient for study; neither system by itself establishes effects during human aging.
Epithelial competition can constrain tumors, while stromal signaling can enhance invasion, so suppressing expanding clones in aged human mosaics may remove protective competitors rather than genuinely dysfunctional lineages.
The assumption concerns families of related cells in body coverings and organ linings, alongside the supporting tissue around them. It proposes that competition among the lining cells can restrain dangerous growth while messages from surrounding support cells can encourage invasion. If that distinction holds during human aging, the consequences of suppressing a growing cell family would depend on what it does to its neighbors and to tissue function, rather than simply how much it expands.
The supplied evidence does not establish the combined premise in aging human tissues. S1 describes different patterns of altered-cell growth in different regions of mouse skin, without testing removal of protective competitors. S4 reports reduced adhesion and increased competition after induction of a protein in cells surrounding a cancer, but does not establish that this competition protects against invasion or that suppressing a competitor releases invasion. S3 and S8 do not test that distinction either. This small set of background sources is too indirect to judge the premise; it does not refute it.S1S3S4S8
The same question asked without the part nothing read establishes:
- During human aging, does suppressing expanding families of lining cells increase, decrease, or leave unchanged invasion and tissue function across repeated repair?
- What distinguishes expanding families of lining cells whose suppression increases invasion from those whose suppression improves tissue function across repeated repair?
- Suppression increases invasion Under the proposed protective-competition mechanism, suppression removes cells that restrain dangerous neighbors, allowing those neighbors to spread further into surrounding tissue. A reduction in the targeted family would then coexist with increased danger, so reduced expansion alone would not establish a beneficial outcome.
- Suppression improves repair without increasing invasion If the targeted family impairs tissue function, its suppression could reduce that interference during subsequent repair. Improved function without increased invasion would support a beneficial effect of suppression in that setting, although it would not by itself establish the precise mechanism.
- Suppression improves function but increases invasion An expanding family could, within the question's proposed framework, impair tissue work while also restraining dangerous neighbors. Removing it could therefore improve repair and increase invasion at the same time, making either measurement alone an incomplete account of the outcome.
- Suppression changes neither outcome If neither invasion nor tissue function changes, suppressing expansion would show no benefit or harm on those measured outcomes. That result alone would not establish whether the family had no relevant role or whether other cells maintained its effects.
The proposed causal chain begins with suppressing an expanding cell family, which changes which cells remain in the tissue. If that family restrains dangerous neighbors, removing it could remove a barrier to their spread into surrounding tissue. If the family instead impairs normal tissue work, removing it could have a different consequence for repeated repair. Mistaking protective growth for harmful growth could therefore increase invasion, while mistaking harmful growth for protection could preserve impaired tissue function. These are conditional consequences of the question's proposed mechanism, not outcomes demonstrated by the supplied sources.
RL-1 epithelial competition can constrain tumors, while RL-1 stromal signaling can enhance invasion; human inflammatory selection lacks longitudinal aging safety.
Across months–years of renewal, lineage expansion must not progressively impair specialization, growth control or function; neutral expansion is permissible.
The sign of clone suppression in aged human mosaics is unknown when resident protection, tissue function and invasion are evaluated together.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
SCOUT 1 from microbial chemical toxicology, conditional: In an aging human mucosal mosaic with a verified active genotoxic producer, loss of a resident's functional barrier contribution during removal-to-repair may increase the toxin dose delivered to surviving renewing cells. A subset might survive with newly acquired heritable lesions that causally confer sustained invasiveness on their descendants. This requires three distinct unverified links: removal increases local exposure, exposure creates surviving new lesions, and those lesions contribute causally to later invasion. The resident's protection here is functional exclusion of genotoxic exposure, not necessarily superior clonal fitness. Apparent coverage alone does not establish mucus, junction, polarity or secretory protection; even viability-preserving suppression may increase exposure, whereas extraction with rapid functional replacement may not. Toxin-dependent selection of an already invasive or resistant lineage, or transient signaling, is a separate compatible explanation. Removing a dysfunctional resident could improve later mature output while transiently increasing exposure. Preventing this channel could reduce the birth of new dangerous descendants but need not change the SPV_9 of existing dangerous clones; mutation acquisition, lineage growth and invasion remain distinct. No general claim that every aging epithelium carries the required producer is made.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Proposed common-condition test: use a defined older-donor intestinal epithelial mosaic supporting documented luminal microbial contact and repair, with banked, deeply characterized ancestral lineages split across conditions. Cross retention, viability-preserving suppression and controlled small-area removal with verified toxin-competent, toxin-deficient and complemented producer conditions plus sterile controls. The matched reagent pair is an experimental target: verify microbial growth, metabolism, adhesion, community composition and proximity; equal bacterial counts are not equal delivered dose. Match initial deletion, non-toxin injury, starting producer burden, baseline nutrients, initial corpse material and matrix; downstream toxin-induced corpse release is not matched away in the total-effect arm. Measure functional permeability and local toxin activity/contact over time and do not force downstream toxin-mediated injury equal, because it lies on the proposed causal path. First establish whether removal actually increases delivered exposure and DNA adducts/damage in surviving renewal cells. If it does, follow barcodes, repeated samples and descendant phylogenies to nominate sequence changes acquired after exposure and before phenotype, reporting deep-baseline detection limits rather than claiming every rare pre-existing subclone was absent. A new mutational signature or passenger plus expansion is insufficient. After toxin withdrawal, compare descendants in a shared uninjured niche and matrix; reconstruct a nominated acquired lesion in the appropriate ancestral background or correct it in the descendant, with matched genetic controls, to test causal invasive behavior and possible cooperation with pre-existing drivers. Under the hypothesis, specific toxin interruption reduces the acquired-lesion-mediated component, and restoration of verified delivered exposure is predicted to restore its population-level contribution under a viable exposure regime, not the identical lesion or descendant in every replicate. Toxin dependence alone can also reflect selective killing or growth of pre-existing invasive lineages; ancestry and lesion causality distinguish these routes. Sterile or toxin-negative arms should lack this toxin-mediated new-lesion component, while other release mechanisms can persist. A finite negative result bounds the tested dose/time and detectable lineage frequency, not all late events. Measure absolute descendant production, clone fractions with denominator, mature barrier recovery and basement-membrane crossing separately. Matrix-dependent invasion without required new causal lesions supports a matrix contribution and can coexist with genotoxicity. Additional required discriminators and bounded interpretations: Measure local delivered dose, activity/contact, adducts/damage, cell death/arrest and surviving descendant lesions in banked ancestral lines under matched toxin-deficient and complemented conditions. Bound pre-existing ancestry and require separate lesion-function evidence before predicting invasive descendants; current microbiome composition cannot establish past exposure. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Compare retention, suppression and the specified removal procedure using delivered toxin activity/contact, functional barrier measures and surviving-renewal-cell damage. Proceed to the lesion-mediated prediction only if that first link is supported in the proposed model; absence under rapid functional replacement bounds that procedure, not all epithelial removal. Preserve banked ancestral lines, baseline detection bounds, time-resolved ancestry and post-exposure lesion timing. Test nominated new changes in the relevant ancestral/descendant genetic background, with existing drivers characterized, and require a causal contribution to sustained anatomical invasion after washout in a justified common niche rather than signature enrichment or toxin dependence alone. Across independent ancestral replicates compare exposure-linked rates and distributions of surviving causal-lesion descendants, with uncertainty, delivered dose, cell loss/arrest and adequate follow-up recorded. Restoration means recovery of the conditional distributional contribution within a justified exposure regime; a finite unmatched stochastic realization is not falsification, and no universal monotonic dose response is asserted. Report both total-effect and pulse-clamped estimates with their distinct intervention conditions; track all initial lineages, death and surviving descendants, then report survivor-conditional quantities as such. Preserve the toxin-to-death-to-feeding chain in total-effect comparisons and use ancestral matching rather than treating survivor selection as randomization. Where indicated, test justified lesion sets and characterized cooperating state/background with matched genetic controls. Retain the exposure-to-ancestry chain and test sustained basement-membrane crossing in a shared niche justified for the original tissue. Invasion enabled only by an artificial permissive matrix does not establish consequential invasion caused by removal in aging tissue. Current finding-specific qualification: Toxin restoration remains a conditional distributional prediction, with distinct estimands per initial lineage, per exposure and conditional on survival. A pulse-clamped contrast is a separate controlled effect only if the clamp is feasible and does not independently alter delivered toxin, susceptibility or relevant repair functions; feasibility is not established. Prespecify follow-up and report the probability of at least one causal-lesion descendant per starting lineage, absolute causal-lesion descendant counts per initial lineage, and any exposure-normalized rate with its exposure denominator and uncertainty; separately label survivor-conditional quantities and follow all initial lineages including deaths/arrests. Validate any pulse clamp for exposure and susceptibility; if validation fails, omit its isolated causal interpretation while retaining the total-effect arm with toxin-induced injury, death and feeding intact. Validate producer deletion/complementation ecology and delivery; toxin dependence alone still does not distinguish new-lesion causality from selection.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies measurable reductions, restoration and absence of a toxin-mediated acquired-lesion component under stated conditions. No rival prediction is supplied. The chunk states an observable invasion outcome conditional on whether new causal lesions are required, and an explicit condition for supporting resident protection. These go beyond intentions to measure or investigate. No rival prediction is supplied. The chunk states a conditional prediction of distributional recovery under restoration and explicitly limits what would count as falsification. No rival prediction is supplied. The supplied chunk states a limitation on causal interpretation but predicts no observable outcome, comparison, or rejection condition. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
A contained epithelial–microbial model is conceptually testable; no validated matched strains, exposure dose, donor range, latency or causal lesion is supplied. Begin with delivered exposure and surviving-cell injury before attempting a long lesion-to-invasion chain. Deep baseline sampling and phylogeny constrain but cannot eliminate rare pre-existing ancestry; toxin withdrawal, shared-background phenotype tests and lesion reconstruction/correction strengthen causal attribution. If lesion function or strain selectivity cannot be established, report toxin dependence or mutagenesis only and leave new-lesion-mediated invasion unresolved. No deliberate human genotoxic exposure or antibiotic/microbiome regimen is proposed.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Proposed common-condition test: use a defined older-donor intestinal epithelial mosaic supporting documented luminal microbial contact and repair, with banked, deeply characterized ancestral lineages split across conditions. Cross retention, viability-preserving suppression and controlled small-area removal with verified toxin-competent, toxin-deficient and complemented producer conditions plus sterile controls. The matched reagent pair is an experimental target: verify microbial growth, metabolism, adhesion, community composition and proximity; equal bacterial counts are not equal delivered dose. Match initial deletion, non-toxin injury, starting producer burden, baseline nutrients, initial corpse material and matrix; downstream toxin-induced corpse release is not matched away in the total-effect arm. Measure functional permeability and local toxin activity/contact over time and do not force downstream toxin-mediated injury equal, because it lies on the proposed causal path. First establish whether removal actually increases delivered exposure and DNA adducts/damage in surviving renewal cells. If it does, follow barcodes, repeated samples and descendant phylogenies to nominate sequence changes acquired after exposure and before phenotype, reporting deep-baseline detection limits rather than claiming every rare pre-existing subclone was absent. A new mutational signature or passenger plus expansion is insufficient. After toxin withdrawal, compare descendants in a shared uninjured niche and matrix; reconstruct a nominated acquired lesion in the appropriate ancestral background or correct it in the descendant, with matched genetic controls, to test causal invasive behavior and possible cooperation with pre-existing drivers. Under the hypothesis, specific toxin interruption reduces the acquired-lesion-mediated component, and restoration of verified delivered exposure is predicted to restore its population-level contribution under a viable exposure regime, not the identical lesion or descendant in every replicate. Toxin dependence alone can also reflect selective killing or growth of pre-existing invasive lineages; ancestry and lesion causality distinguish these routes. Sterile or toxin-negative arms should lack this toxin-mediated new-lesion component, while other release mechanisms can persist. A finite negative result bounds the tested dose/time and detectable lineage frequency, not all late events. Measure absolute descendant production, clone fractions with denominator, mature barrier recovery and basement-membrane crossing separately. Matrix-dependent invasion without required new causal lesions supports a matrix contribution and can coexist with genotoxicity. Additional required discriminators and bounded interpretations: Measure local delivered dose, activity/contact, adducts/damage, cell death/arrest and surviving descendant lesions in banked ancestral lines under matched toxin-deficient and complemented conditions. Bound pre-existing ancestry and require separate lesion-function evidence before predicting invasive descendants; current microbiome composition cannot establish past exposure. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Compare retention, suppression and the specified removal procedure using delivered toxin activity/contact, functional barrier measures and surviving-renewal-cell damage. Proceed to the lesion-mediated prediction only if that first link is supported in the proposed model; absence under rapid functional replacement bounds that procedure, not all epithelial removal. Preserve banked ancestral lines, baseline detection bounds, time-resolved ancestry and post-exposure lesion timing. Test nominated new changes in the relevant ancestral/descendant genetic background, with existing drivers characterized, and require a causal contribution to sustained anatomical invasion after washout in a justified common niche rather than signature enrichment or toxin dependence alone. Across independent ancestral replicates compare exposure-linked rates and distributions of surviving causal-lesion descendants, with uncertainty, delivered dose, cell loss/arrest and adequate follow-up recorded. Restoration means recovery of the conditional distributional contribution within a justified exposure regime; a finite unmatched stochastic realization is not falsification, and no universal monotonic dose response is asserted. Report both total-effect and pulse-clamped estimates with their distinct intervention conditions; track all initial lineages, death and surviving descendants, then report survivor-conditional quantities as such. Preserve the toxin-to-death-to-feeding chain in total-effect comparisons and use ancestral matching rather than treating survivor selection as randomization. Where indicated, test justified lesion sets and characterized cooperating state/background with matched genetic controls. Retain the exposure-to-ancestry chain and test sustained basement-membrane crossing in a shared niche justified for the original tissue. Invasion enabled only by an artificial permissive matrix does not establish consequential invasion caused by removal in aging tissue. Current finding-specific qualification: Toxin restoration remains a conditional distributional prediction, with distinct estimands per initial lineage, per exposure and conditional on survival. A pulse-clamped contrast is a separate controlled effect only if the clamp is feasible and does not independently alter delivered toxin, susceptibility or relevant repair functions; feasibility is not established. Prespecify follow-up and report the probability of at least one causal-lesion descendant per starting lineage, absolute causal-lesion descendant counts per initial lineage, and any exposure-normalized rate with its exposure denominator and uncertainty; separately label survivor-conditional quantities and follow all initial lineages including deaths/arrests. Validate any pulse clamp for exposure and susceptibility; if validation fails, omit its isolated causal interpretation while retaining the total-effect arm with toxin-induced injury, death and feeding intact. Validate producer deletion/complementation ecology and delivery; toxin dependence alone still does not distinguish new-lesion causality from selection.
- Rival 01 of 03What would separate them
Cell fusion may restore growth control through resident genes in aging epithelial tissue predicts: Proposed common-condition test: begin in sterile immune-free older-donor organotypic mosaics of one specified epithelial site, with traceable resident/invader nuclear genomes, measured local contacts, successful heterotypic replacement, baseline nutrient delivery, functional permeability and matrix. First live-track two viable parental cells becoming one viable hybrid, then establish nuclear organization, phased parental genomes, copy number/ploidy and subsequent fate; exclude doublets, engulfed nuclei, undegraded phagocytosed material, label or DNA transfer and transient colocalization. Quantify assay recovery and whether hybrid incidence and the descendants restrained could account for the field-level effect; an undetected rare event gives a sensitivity-dependent bound. Authentic fusion must precede durable arrest, but a necessary but not uniquely sufficient allele-dependence test is loss of a nominated functional resident allele within an established hybrid followed by release of arrest, and allele-specific restoration followed by restored restraint, with matched ploidy, fusion history and generic fusion-stress controls, measuring allele-dependent checkpoint changes without matching them away. Compare appropriate same-ploidy fusion controls to separate functional allele rescue from generic extra-DNA or fusion stress. If allele identity remains unknown, report fusion-associated arrest only. After that, a validated resident-specific fusion block should reduce new protective hybrid formation and increase viable invader-derived output relative to rescue, provided adhesion, polarity, secretome, local encounter geometry, replacement hazard, nutrient access and barrier function remain comparable. Test a new invader challenge separately from already formed hybrids. Division-arrested viable residents should retain only the fusion-attributable protection within the window where actual encounters, fusion and mature function persist. Track late chromosome loss, escape, mature contribution and basement-membrane crossing independently of arrest and cell number. A selective fusion/allele null with adequate event detection limits the proposed contribution in this setting; generic ploidy-dependent arrest favors a hybrid-stress alternative. Factorial matrix swaps can reveal an additional matrix contribution, including retained soluble factors, ligands and geometry; they do not eliminate complementation unless validated fusion/allele contrasts add no effect within those matrix strata. Additional required discriminators and bounded interpretations: Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. First calibrate recovery and live-track spontaneous two-parent-to-one viable hybrid events, phase parental nuclear genomes and copy number, and follow viability and arrest before attempting allele tests. If none are detected, give a tissue/window/recovery-dependent upper bound; missing or insufficiently detectable events leave wider-subset support unknown. Conditional on viable selective edits, physiological restoration of the nominated deficient function should reinstate allele-mediated restraint, whereas matched controls and independent edits test dosage or linked-state alternatives. Measure checkpoint changes as possible mediators, distinguishing them from generic fusion stress. If selectivity, viability or defect identity cannot be established, report allele-associated arrest or unresolved identification rather than rejection or proven complementation. Estimate incident hybrid events per time and their counterfactual viable descendant output avoided per event with uncertainty, including unfused invaders and hybrid persistence/loss. Integrate these contributions through repairs and compare with the observed field effect; sustained arrested-hybrid accumulation alone cannot account for a formation-mediated protective flux. Before the contrast, pilot and prespecify a window based on actual local contacts, fusion incidence, resident allele expression and mature/barrier function, then independently validate those conditions during the comparison. Retained fusion-attributable protection in that window does not predict months–years of adequate replenishment; follow repeated repair separately and call the isolated comparison inconclusive if its controls fail. Compare cumulative viable invasive descendants, hybrid persistence/escape and mature tissue contribution across successive repairs, with late chromosome and phenotype tracking. Report the observed horizon and remaining tail uncertainty explicitly; no early arrest or arbitrary finite horizon certifies long-term safety. Current finding-specific qualification: The avoided output of a fused invader is an unobserved counterfactual: an arbitrary unfused invader need not be exchangeable because fusion may select contact histories and cell states. A formation-mediated field contribution remains conditional on a justified comparable-ancestry/history contrast, not on hybrid prevalence. Constrain avoided descendant output using comparable ancestral lineages and pre-event contact/state histories together with selective formation loss/rescue; report residual selection uncertainty and sensitivity bounds if comparability fails. Integrate incident events, counterfactual output, hybrid persistence/loss, late escape and unfused descendants over the same horizon. No event frequency or quantitative protective effect is supplied.
- Rival 02 of 03What would separate them
Resident daughter cells may restrain epithelial invaders by replacing their renewing positions predicts: Proposed common-condition test: in a sterile immune-free older-donor epithelial mosaic of one site, track a complete resident–invader boundary fate ledger: division, daughter retention and differentiation, migration, extrusion direction, death, vacancies and actual replacement of viable invader renewing positions. Keep invader genotype, initial lineage composition, matrix, baseline nutrients and functional permeability comparable and measure local contact geometry, density, cell size, tension proxies and signaling. First test whether gross J_R predicts directly observed h_RI at all. Then reversibly alter resident output with a resident-autonomous perturbation and rescue during the measured window before mature function or coverage diverges, with direct invader-exposure controls. If the mechanism operates, a reduction in successful h_RI should reduce position-loss events and increase absolute renewing-invader growth by the event-accounted amount when other rates are unchanged; restoring h_RI with competent fusion-incompetent cells should restore that component of restraint. Equal J_R alone does not establish equivalent replacements, and no mutation-count-independent invasion claim is made without equivalent contacts, hazards and function. Estimate parameters from mutually exclusive observed fates, predict held-out episodes, and vary geometry explicitly rather than absorbing every result into kappa_R. Gross production changes with no h_RI change and no growth effect favor a contact/occupancy explanation over a transferable gross-flux law. Coupled mechanical and replacement effects support spatial turnover competition and limit an independent constant-coefficient model. Measure mature output and next-cycle reserve independently; a lower g_I cannot compensate for their deterioration. If toxin or feeding interruption removes an ablation-associated excess while h_RI stays low, this limits flux loss as a sufficient or dominant cause only when invader growth capacity is preserved. Nutrients can increase lambda_I or survival enough to overcome high h_RI without disproving displacement. Cross matrix strata that preserve both lineages and allow events; matrix effects may alter h_RI or other rates and can coexist, while a selective h_RI null bounds this contribution. Report SPV_9 with denominator growth and anatomical crossing separately. Additional required discriminators and bounded interpretations: Before observing held-out net growth, estimate time/geometry-conditioned rate relationships on other repairs, then integrate their predicted local trajectories and propagate event-recovery, parameter and ambiguous-fate uncertainty. Compare predicted absolute I and separate tissue clone fractions with observations. A failed stationary approximation limits that reduction, not the possibility of displacement; post hoc reconstruction from the same outcome episode is bookkeeping, not predictive transfer. Follow P_R(t), mature daughter production, D_R survival/lifespan, tissue-specific mature function, growth control and reserve available at the next repair jointly. Integrate mature inflow and loss over time; a lower renewing-invader growth rate or higher J_R does not establish beneficial aging renewal or adequate specialization. Track divisions, daughter states, nondivision loss and mature survival separately; audit migration/dedifferentiation and include their net flows or restrict the model to a justified closed interval. Estimate time/geometry-conditioned rates and prospectively integrate held-out repair trajectories with uncertainty, preserving specialized function as an independent outcome. Directly count gross progenitor daughters per measured area/time and separately follow which reach and causally replace viable invader positions. Record changing area and boundaries; compare J_R with the event-resolved hazard in held-out geometry/time strata, allowing no relation or changing kappa_R. Freeze training-derived time/geometry relationships and predictive uncertainty before held-out episodes, including reciprocal replacement and repair-stage changes; use observable starting state and prespecified inputs. Recounting all held-out fates afterward checks accounting only. If no useful stable relation survives, retain event-caused displacement conditionally and reject or bound that transportable reduction, not replace its mechanism. Prespecify invader-derived hybrid membership and count each viable descendant once in a lineage numerator, track renewing and differentiated compartments and denominator dynamics, and report SPV_9 per year separately from absolute growth and crossing. Check observed count consistency and uncertainty; changing fractions or mutation counts alone cannot establish malignancy or whole-human aging benefit. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Use time-resolved boundary imaging plus selective resident output/incorporation perturbation and rescue, comparing the ordering of viable position occupancy, incorporation and invader exit. Prespecify uncertain-order cases and bound their influence; preserved area or gross J_R alone cannot identify replacement causation. Calibrate fate observation and missed events; report growth bounds under plausible assignments of ambiguous events without allocating them to fit the equation. Track displaced descendants as viable differentiated, basally displaced, dead or unresolved separately: loss from the renewing compartment is not automatically loss of the clone or anatomical safety. Current finding-specific qualification: The exponential compartment trajectory applies to a deterministic or justified conditional-mean reduction with homogeneous prescribed rates and represented flows; it is not a realized rare-clone trajectory or an extinction law. For random history-dependent rates, dE[I_s]/dt=E[g_s I_s]+E[net flows], and E[g_s I_s] generally differs from E[g_s]E[I_s]. A product-of-means closure requires independent justification. Prespecify and validate the closure on training repairs or integrate an explicit history-dependent stochastic model; propagate event, rate and demographic variability into held-out expected counts and outcome distributions. Report realized counts and extinction separately, without replacing the already defined time-local hazard by the pooled interval estimator. Compare equally prespecified contact/occupancy models. Match baseline mechanics; measure mechanics caused by daughter incorporation as part of its total displacement effect instead of clamping that mediator. A failed closure or proportional hazard reduction limits that reduction, not event-caused displacement.
- What would separate them
Dead resident cells may feed invasive lineages during epithelial repair predicts: Proposed common-condition test: in a defined older-donor epithelial mosaic with a barcoded pre-existing invasive lineage, initially exclude microbes and immune cells. Compare resident retention, viability-preserving suppression, killing with retained debris and physical extraction, recording local coverage, successful replacement hazard, mature function, death mode, nutrient delivery, matrix and non-target injury. Prelabel resident biomass, wash and chase, then measure the amount, chemical species and kinetics released, cleared and reaching invaders. Trace label through extracellular species into purified newly synthesized invader macromolecules and, for survival/maintenance, quantify catabolic products and energetic use; exclude residual medium/free label, adherent corpses, undegraded engulfed material and acellular carryover. Add macrophages only in separate arms to distinguish direct from indirect recycling. Quantify absolute births, deaths, net newly produced biomass and invasive events. Use carbon/nitrogen or substrate-relevant mass balance, with medium inputs, recovered corpse material and metabolic losses, to ask whether accessible assimilated material and its measured yield plausibly account for extra output; a limiting trace substrate need not supply most biomass, but its necessity and quantitative capacity must be shown. Test measured resident-equivalent concentration/time courses under baseline-supporting, physiologically defensible nutrient/perfusion and clearance conditions; dependence manufactured by starvation does not establish an ordinary-human route. After identifying a candidate limiting substrate, use orthogonal invader-specific uptake/conversion perturbations with target engagement and demonstrated loss of relevant flux, rescue the pathway, and compare equally injured invaders supplied with non-corpse nutrients. Baseline fitness alone cannot exclude a general repair-stress or signaling effect, and one redundant transporter block is not a complete salvage interruption. Under the hypothesis, selective loss of material flux reduces the extra production/survival component and its restoration rescues it. Fraction sufficiency at measured kinetics is supplementary: separately interrupt signaling versus metabolic conversion where feasible and test alternative nutrient rescue to distinguish instructions from feeding. If signaling drives extra growth despite adequately verified loss of material flux, the feeding contribution is bounded; if selective separation is impossible, label plus growth does not establish nutrition. High-flux or fusion-competent resident add-back can consume the pulse or suppress fed invaders, so restored restraint does not disprove feeding. Measure actual uptake and birth/loss terms in such factorial arms; matrix may separately determine crossing. Null invasion alone does not exclude nutrition, and null single-step perturbation alone does not exclude redundant salvage. Additional required discriminators and bounded interpretations: For the survival branch extend substrate-relevant mass balance to extracellular metabolites, intracellular flux, catabolic products and energetic/maintenance use, while separating contamination and indirect macrophage recycling. Couple measured flux to absolute survival/death and selective loss/rescue; absence of retained biomass label alone cannot exclude catabolic feeding, and catabolic label alone cannot establish its causal benefit. Bound accessible amount, uptake rate and plausible output supported using the measured requirement/yield and uncertainty; test graded physiologically defensible availability with alternative nutrient rescue and pathway-selective loss/rescue when feasible. Do not equate bulk isotope enrichment with causal contribution or claim a numerical capacity absent measurements. Compare tracked fates, absolute growth and post-colonization balance in matched normal and tumor contexts with recorded genotypes and perturbation/rescue. Independently test interlineage competition and serial mature/barrier function; a fitness sign reversal alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor epithelial model compare retained versus removed residents with matched initial wounding and adequate functional replacement, and separately vary immune presence when feasible. Track resident–invader contacts, direct losses, basal extrusion, matrix and mature function. Resident protection is supported only as a measured contribution after removal-induced injury alternatives are tested; immune-free behavior alone does not establish in-vivo immunity irrelevance. Compare genotype-resolved survival and fate under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/rescue and serial mature/barrier outcomes. Prospectively track cancer outcomes separately. Any colitis-context resistance prediction does not imply an age-only benefit or make a resident universally protective. Factorially vary defined matrix chemistry/architecture and selective signaling perturbation/rescue within a recorded genotype and matched repair context; measure actual crosslinks, focal signaling, basement-membrane crossing, mutation acquisition and wound strength separately. A matrix contribution can coexist with all four native mechanisms and does not establish absence of new mutations merely because none were intended. Quantify release, delivery, uptake and use versus viable/suppressed-resident secretion, and test whether a limiting material input causes extra survival or production after controlling independent instructive signaling while allowing downstream nutrient-state signaling to vary. Equivalent dead mass from another lineage predicts equivalence only when species, composition, death mode, clearance and local availability are matched. Demonstrate loss of the relevant material flux, intact matched-injury responses and alternative-nutrition growth, and orthogonal pathway-specific rescue. If redundancy or inseparable signaling prevents these controls, report transfer plus association and bounds, not proven nutritional causation; a single null transporter perturbation does not reject the mechanism. Measure local release, availability, uptake and output over an explicitly justified delivery/clearance range anchored to the chosen tissue once such data exist. Report the range as unvalidated until measured. An immune-free arm isolates direct transfer; separately add phagocyte clearance/recycling and record net effects before making any in-vivo inference. Current finding-specific qualification: Material feeding can cause downstream nutrient-state signaling. Preserving independent instructive signaling in the nutrition contrast must not mean clamping signaling caused by restored limiting material or energy. The rival is instruction independent of that limiting material function, not every signaling response to nutrition. Where selective separation is feasible, compare material-use loss and orthogonal pathway or suitable nutrient restoration while preserving independent instructive exposure and matched-injury/alternative-nutrition competence, allowing downstream nutrient-state responses to vary. Attribute assimilative and catabolic/maintenance flux to viable invaders with the existing sterile, acellular and separate-phagocyte controls. If material and instructive roles cannot be separated, report transfer, association and substrate-specific quantitative bounds rather than proven nutritional causation.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 1 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: 2020 ACVIM Forum On Demand Research Abstract Program..
6 papers retrieved around this hypothesis
- UEG Week 2024 Moderated Posterseuropepmc:PMC:PMC11471002 · unavailable · 0 characters stored
- 2020 ACVIM Forum On Demand Research Abstract Program.PMID 33037851 · full_text · 886,057 characters stored
- Publication Onlyeuropepmc:PMC:PMC13254489 · unavailable · 0 characters stored
- 2026 ACVIM Forum Research Abstract Program June 10 – October 31, 2026 Seattle, Washingtoneuropepmc:PMC:PMC13540732 · unavailable · 0 characters stored
- UEG Week 2024 Oral Presentationseuropepmc:PMC:PMC11470993 · unavailable · 0 characters stored
- Abstracts from the 57th European Society of Human Genetics (ESHG) Conference: Hybrid Posterseuropepmc:PMC:PMC11627200 · unavailable · 0 characters stored
0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 1 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.